Biomarkers in long COVID-19: A systematic review

YJ Lai, SH Liu, S Manachevakul, TA Lee… - Frontiers in …, 2023 - frontiersin.org
Purpose Long COVID, also known as post-acute sequelae of COVID-19, refers to the
constellation of long-term symptoms experienced by people suffering persistent symptoms …

Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review

S Duong-Quy, T Vo-Pham-Minh, Q Tran-Xuan… - Pulmonary …, 2023 - Springer
Patients with coronavirus disease 2019 (COVID-19) usually suffer from post-acute sequelae
of coronavirus disease 2019 (PASC). Pulmonary fibrosis (PF) has the most significant long …

[HTML][HTML] COVID-19 disease and autoimmune disorders: A mutual pathway

M Al-Beltagi, NK Saeed, AS Bediwy - World Journal of …, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is a real challenge for humanity with high
morbidity and mortality. Despite being primarily a respiratory illness, COVID-19 can affect …

Matrix metalloproteinase-7 and osteopontin serum levels as biomarkers for biliary atresia

B Aldeiri, T Si, Z Huang, N Torner, Y Ma… - Journal of pediatric …, 2023 - journals.lww.com
Objectives: Matrix metallopeptidase-7 (MMP-7) and osteopontin (OPN) are important
components in the pathophysiology of fibrosis in biliary atresia (BA). There has been much …

SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling

BD López-Ayllón, A de Lucas-Rius… - Frontiers in …, 2023 - frontiersin.org
SARS-CoV-2, the cause of the COVID-19 pandemic, possesses eleven accessory proteins
encoded in its genome. Their roles during infection are still not completely understood. In …

Correlation between hepatocyte growth factor (HGF) with D-dimer and interleukin-6 as prognostic markers of coagulation and inflammation in long COVID-19 …

B Zaira, T Yulianti, J Levita - Current Issues in Molecular Biology, 2023 - mdpi.com
In general, an individual who experiences the symptoms of Severe Acute Respiratory
Syndrome Coronavirus 2 or SARS-CoV-2 infection is declared as recovered after 2 weeks …

The correlation between serum levels of laminin, type IV collagen, type III procollagen N-terminal peptide and hyaluronic acid with the progression of post-COVID-19 …

D Yu, G Yin, J Lei, Y Gong, L Zheng, D He… - Frontiers in Cell and …, 2024 - frontiersin.org
COVID-19 patients often suffer from post-COVID-19 acute sequelae (PASC). Pulmonary
fibrosis has the most significant long-term impact on the respiratory health of patients, known …

Pharmacological approaches to pulmonary fibrosis following COVID-19

S Lassan, T Tesar, J Tisonova… - Frontiers in …, 2023 - frontiersin.org
Background: In the past few years, COVID-19 became the leading cause of morbidity and
mortality worldwide. Although the World Health Organization has declared an end to COVID …

Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis

J Tan, Q Xue, X Hu, J Yang - Journal of Translational Medicine, 2024 - Springer
Idiopathic pulmonary fibrosis (IPF) is a globally prevalent, progressive disease with limited
treatment options and poor prognosis. Because of its irreversible disease progression, IPF …

[HTML][HTML] Post–COVID-19 Syndrome Clinical Pathway for the US Veterans Health Administration

CL Campos, C Nguyen, K Crothers… - Journal of clinical …, 2023 - ncbi.nlm.nih.gov
Abstract The Department of Veterans Health Affairs (VHA) has launched 22 multispecialty
post–COVID-19 clinics across the US for the growing number of veterans experiencing long …